ARTICLE | Company News
Lorus, Zoticon Bioventures. deal
October 20, 2008 7:00 AM UTC
The parties added Central America to the territories covered under Zoticon's license to Virulizin from Lorus' GeneSense Technologies Inc. subsidiary. Also, Lorus received a $150,000 milestone payment...